Open access
56
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
Josep Darbà1 Department of Economics, Universitat de BarcelonaCorrespondence[email protected]
, Gabriela Ramírez2 BCN Health Economics & Outcomes Research S.L., Barcelona
, Juan L García-Rivero3 Hospital Laredo, Cantabria
, Sagrario Mayoralas4 Hospital Ramón y Cajal, Madrid
, José Francisco Pascual5 Hospital General Universitario de Alicante, Alicante
, Diego Vargas6 Hospital de Alta Resolución el Toyo, Andalusia
& Adi Bijedic7 Market Access and HEOR Department, TEVA Pharmaceutical, Madrid, Spain
show all
Pages 127-137
|
Published online: 10 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.